Potentiation Enhancement of Topoisomerase Activity as a Mechanism of Breakage and Cytotoxicity by Tumor Necrosis Factor : Potentiation of Topoisomerase Inhibitor-induced DNA Strand
暂无分享,去创建一个
[1] N. Hanna,et al. Synergistic antitumor effects of topoisomerase inhibitors and natural cell-mediated cytotoxicity. , 1989, Cancer research.
[2] J. Vilček,et al. Enhancement of cAMP levels and of protein kinase activity by tumor necrosis factor and interleukin 1 in human fibroblasts: role in the induction of interleukin 6. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[3] R. Benbow,et al. Regulation of Xenopus laevis DNA topoisomerase I activity by phosphorylation in vitro. , 1988, Biochemistry.
[4] L. Liu,et al. Identification of mammalian DNA topoisomerase I as an intracellular target of the anticancer drug camptothecin. , 1988, Cancer research.
[5] S. Crooke,et al. Tumour necrosis factor (cachectin) induces phospholipase A2 activity and synthesis of a phospholipase A2-activating protein in endothelial cells. , 1988, The Biochemical journal.
[6] C. F. Bennett,et al. LTD4 Receptors and Signal Transduction Processes , 1988 .
[7] Y. Niitsu,et al. Synergistic cytotoxicity of recombinant human TNF and various anti-cancer drugs. , 1988, Immunopharmacology and immunotoxicology.
[8] P. Schein,et al. Elevated DNA topoisomerase II activity in nitrogen mustard-resistant human cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[9] J. Vilček,et al. Tumor necrosis factor and interleukin-1 cause a rapid and transient stimulation of c-fos and c-myc mRNA levels in human fibroblasts. , 1987, The Journal of biological chemistry.
[10] D. S. Coffey,et al. Tumor necrosis factor enhances the in vitro and in vivo efficacy of chemotherapeutic drugs targeted at DNA topoisomerase II in the treatment of murine bladder cancer. , 1987, The Journal of urology.
[11] D. S. Coffey,et al. Synergistic enhancement by tumor necrosis factor of in vitro cytotoxicity from chemotherapeutic drugs targeted at DNA topoisomerase II. , 1987, Cancer research.
[12] W. Ross,et al. DNA topoisomerase II: a primer on the enzyme and its unique role as a multidrug target in cancer chemotherapy. , 1987, Pharmacology & therapeutics.
[13] J. Larrick,et al. Tumor necrosis factor stimulates interleukin-1 and prostaglandin E2 production in resting macrophages. , 1986, Biochemical and biophysical research communications.
[14] L. Liu,et al. DNA damage by antitumor acridines mediated by mammalian DNA topoisomerase II. , 1986, Cancer research.
[15] D. Stern,et al. Modulation of endothelial cell hemostatic properties by tumor necrosis factor , 1986, The Journal of experimental medicine.
[16] B. Beutler,et al. Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts , 1985, The Journal of experimental medicine.
[17] R. Hertzberg,et al. Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. , 1985, The Journal of biological chemistry.
[18] J. Tavernier,et al. Binding of human tumor necrosis factor to high affinity receptors on HeLa and lymphoblastoid cells sensitive to growth inhibition. , 1985, The Journal of biological chemistry.
[19] L. Liu,et al. Identification of DNA topoisomerase II as an intracellular target of antitumor epipodophyllotoxins in simian virus 40-infected monkey cells. , 1985, Cancer research.
[20] B. Aggarwal,et al. Characterization of specific high affinity receptors for human tumor necrosis factor on mouse fibroblasts. , 1985, The Journal of biological chemistry.
[21] Leroy F. Liu,et al. In vivo mapping of DNA topoisomerase II-specific cleavage sites on SV40 chromatin , 1985, Cell.
[22] A. Lazzarin,et al. Rapid killing of actinomycin D-treated tumor cells by human monocytes. II. Cytotoxicity is independent of secretion of reactive oxygen intermediates and is suppressed by protease inhibitors. , 1985, Journal of immunology.
[23] N. Osheroff,et al. Phosphorylation of DNA topoisomerase II by casein kinase II: modulation of eukaryotic topoisomerase II activity in vitro. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[24] L. Liu,et al. Role of topoisomerase II in mediating epipodophyllotoxin-induced DNA cleavage. , 1984, Cancer research.
[25] L. Liu,et al. Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II. , 1984, Science.
[26] D. A. Flick,et al. Comparison of in vitro cell cytotoxic assays for tumor necrosis factor. , 1984, Journal of immunological methods.
[27] L. Liu,et al. Mechanism of antitumor drug action: poisoning of mammalian DNA topoisomerase II on DNA by 4'-(9-acridinylamino)-methanesulfon-m-anisidide. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[28] A. Mantovani,et al. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage. , 1984, Journal of immunology.
[29] G. Riethmüller,et al. A rapid assay for cytotoxicity of unstimulated human monocytes. , 1984, Journal of the National Cancer Institute.
[30] L. Liu,et al. Intercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II. , 1984, The Journal of biological chemistry.
[31] H. Busch,et al. Phosphorylation of purified Novikoff hepatoma topoisomerase I. , 1983, Biochemical and biophysical research communications.
[32] L. Liu,et al. DNA topoisomerases--enzymes that catalyse the breaking and rejoining of DNA. , 1983, CRC critical reviews in biochemistry.
[33] L. Liu,et al. A homogeneous type II DNA topoisomerase from HeLa cell nuclei. , 1981, The Journal of biological chemistry.
[34] L. Liu,et al. Eukaryotic DNA topoisomerases: two forms of type I DNA topoisomerases from HeLa cell nuclei. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[35] K W Kohn,et al. Protein-associated DNA breaks in cells treated with adriamycin or ellipticine. , 1978, Biochimica et biophysica acta.
[36] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.